GSK To Aid 12 European Countries Prepare For Future Pandemic
People and the industry have learned a lot about pandemic management by living through COVID-19. Governments all throughout the world are placing a greater...
COVID-19 Grant Turned To Telehealth Service At MaineHealth
Similar to several other health systems around the nation, COVID-19 forced MaineHealth to act quickly to care for patients remotely in order to protect...
Indian Government Launches Three MSMEs Pharma Programmes
Three programmes were introduced by the Indian government on July 21st to support Micro, Small and Medium-Sized Enterprises (MSMEs) in the pharmaceutical industry. At the...
Overall Coronavirus Monoclonal COVID-19 Variant Treatment
Since 2019, the SARS-CoV-2 that produces COVID-19 has tragically highlighted the fragility of humanity to new coronaviruses by killing 6.3 million people globally.
In order...
FDA Scrutinises 2 Cancer Permits Sans Voluntary Withdrawals
The oncology division of the FDA has recently tightened regulations for expedited approvals and emphasised the significance of patient survival data. Several businesses promptly...
BA.5 Causes Greater COVID-19 Reinfections, But Not Often
It's not your imagination: As infections from the fast mutating BA.5 coronavirus subvariant rise throughout the United States, more people are becoming infected with...
Azurity Gets FDA Nod On Liquid Epilepsy Drug After Rejection
On the second attempt, Azurity Pharmaceuticals was able to secure an FDA nod for its zonisamide oral suspension, making it the first firm to do...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...